'Global Allegiance' of Inspectorates Emerging (Part 2 of 2)
This article was originally published in PharmAsia News
Executive Summary
Drug regulatory agencies around the world are beginning to coordinate their inspection processes, which could reduce global drug manufacturers' burden of hosting multiple GMP inspections. Some are piloting joint inspections, with a pilot for active pharmaceutical ingredient manufacturers concluding next month, and a second for drug product manufacturers under way.
You may also be interested in...
'Global Allegiance' Of Inspectorates Emerging (Part 1 of 2)
Drug regulatory agencies around the world are beginning to coordinate their inspection processes, which could reduce global drug manufacturers' burden of hosting multiple GMP inspections. Some are piloting joint inspections, with a pilot for active pharmaceutical ingredient manufacturers concluding next month, and a second for drug product manufacturers under way
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).